Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
Year-over-year debt growth rate
| Period | Value |
|---|---|
| Q4 2025 | -5.17% |
| Q3 2025 | -4.76% |
| Q2 2025 | -4.39% |
| Q1 2025 | -3.98% |
| Q4 2024 | -3.66% |
| Q3 2024 | -3.41% |
| Q2 2024 | -3.19% |
| Q1 2024 | -0.84% |
| Q4 2023 | -2.82% |
| Q3 2023 | -2.65% |
| Q2 2023 | -2.49% |
| Q1 2023 | -0.73% |
| Q4 2022 | 198.97% |
| Q3 2022 | -14.44% |
| Q2 2022 | -12.35% |
| Q1 2022 | -10.75% |
| Q4 2021 | -9.49% |
| Q3 2021 | -8.30% |
| Q2 2021 | -7.49% |
| Q1 2021 | -6.81% |
| Q4 2020 | -33.46% |
| Q3 2020 | -4.03% |
| Q2 2020 | 31.47% |
| Q1 2020 | -4.80% |
| Q4 2019 | -4.47% |
| Q3 2019 | -4.16% |
| Q2 2019 | -3.95% |
| Q1 2019 | 27007.82% |
| Q4 2018 | -26.31% |
| Q3 2018 | -20.37% |
| Q2 2018 | -16.59% |
| Q1 2018 | -13.87% |
| Q4 2017 | -15.20% |
| Q3 2017 | -6.90% |
| Q2 2017 | -9.18% |
| Q1 2017 | -92.26% |
| Q4 2016 | -39.59% |
| Q3 2016 | -28.23% |
| Q2 2016 | -21.97% |
| Q1 2016 | -17.94% |